FDA Announces Approval of Guidance Document on Meetings with Office of Orphan Products Development

Summary

The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) for a guidance document outlining procedures for meetings with the Office of Orphan Products Development, as required by the Paperwork Reduction Act of 1995.